Opinion: Trump’s trade war is hurting companies like mine — and the biotechnology industry
The trade war with China has forced my company to the brink of closing its doors and facing the real possibility of ending the promising research it has been building…
Many industries have been affected by the Trump administration’s escalating trade war, from agriculture to technology. Few people are talking about the problems faced by small biotech companies and researchers who are unable to move forward with their research due to restrictions on foreign investments.
My company, PepVax Inc., began developing a novel DNA-based treatment for an aggressive form of breast cancer called triple-negative breast cancer in 2013. Last year we worked for almost six months to secure funding from a group of Chinese investors to move our lead
